• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种基于发病率的疾病自然史中共病模式评估模型的描述。

Description of an incidence-based model for Assessing comorbidity patterns in disease natural history.

作者信息

Kiri Victor A

机构信息

Faculty of Pharmaceutical Sciences, University of Port Harcourt, Choba, Nigeria FV&JK Consulting Ltd, Guildford, UK.

出版信息

BMJ Open. 2016 Jul 25;6(7):e012105. doi: 10.1136/bmjopen-2016-012105.

DOI:10.1136/bmjopen-2016-012105
PMID:27456331
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4964210/
Abstract

BACKGROUND

Patients with a chronic disease often suffer from other diseases called comorbidities, which can be important factors in the assessment of risks associated with the disease and its management. However, comorbidities can pose important methodological issues because factors such as time, age, duration and the disease can influence their impact on the risk of interest.

METHODS

To identify comorbidities of a chronic disease, it is common practice to construct 2 separate cohorts of patients-a set with the disease and another as a random sample of patients free of the disease-and compare the event rates for each candidate's comorbidity over a specific period between the 2, while accounting for factors which may confound the results. We describe an incidence-based alternative approach that exploits the longitudinal properties of observational databases to track incident event rates along the natural history of the chronic disease. We illustrate it in a retrospective cohort of patients with chronic obstructive pulmonary disease (COPD) aged 50 and above-each patient with COPD was matched with another without COPD on certain confounding factors.

RESULTS

We obtained 24 079 matched pairs. We found that chronic conditions such as lung cancer, asthma, fracture and osteoporosis were more common in patients with COPD. We also found evidence of time-varying associations.

CONCLUSIONS

Our findings in COPD suggest that time is an important factor and comorbidity studies which are based on information in a single fixed period (such as first year postdiagnosis of COPD) are more likely to report spurious associations.

摘要

背景

患有慢性病的患者通常还患有其他疾病,即共病,这些疾病可能是评估与该疾病及其管理相关风险的重要因素。然而,共病可能带来重要的方法学问题,因为时间、年龄、病程和疾病等因素会影响它们对所关注风险的影响。

方法

为了识别慢性病的共病,常见的做法是构建两组独立的患者队列——一组患有该疾病,另一组是无该疾病患者的随机样本——并比较两者在特定时间段内每种候选共病的事件发生率,同时考虑可能混淆结果的因素。我们描述了一种基于发病率的替代方法,该方法利用观察性数据库的纵向特性,沿着慢性病的自然病程追踪发病事件率。我们在一个50岁及以上慢性阻塞性肺疾病(COPD)患者的回顾性队列中进行了说明——每个COPD患者在某些混杂因素上与另一名无COPD患者进行匹配。

结果

我们获得了24079对匹配对。我们发现肺癌、哮喘、骨折和骨质疏松等慢性病在COPD患者中更为常见。我们还发现了随时间变化的关联证据。

结论

我们在COPD方面的研究结果表明,时间是一个重要因素,基于单一固定时间段(如COPD诊断后第一年)信息的共病研究更有可能报告虚假关联。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a9/4964210/ebfc37026fc8/bmjopen2016012105f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a9/4964210/ebfc37026fc8/bmjopen2016012105f01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c9a9/4964210/ebfc37026fc8/bmjopen2016012105f01.jpg

相似文献

1
Description of an incidence-based model for Assessing comorbidity patterns in disease natural history.一种基于发病率的疾病自然史中共病模式评估模型的描述。
BMJ Open. 2016 Jul 25;6(7):e012105. doi: 10.1136/bmjopen-2016-012105.
2
Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.基层医疗中新诊断慢性阻塞性肺疾病和哮喘的共病模式。
Chest. 2005 Oct;128(4):2099-107. doi: 10.1378/chest.128.4.2099.
3
Epidemiology, severity, and treatment of chronic obstructive pulmonary disease in the United Kingdom by GOLD 2013.英国慢性阻塞性肺疾病的流行病学、严重程度及治疗(依据2013年慢性阻塞性肺疾病全球倡议)
Int J Chron Obstruct Pulmon Dis. 2015 May 13;10:925-37. doi: 10.2147/COPD.S82064. eCollection 2015.
4
Seasonality, risk factors and burden of community-acquired pneumonia in COPD patients: a population database study using linked health care records.慢性阻塞性肺疾病(COPD)患者社区获得性肺炎的季节性、危险因素及负担:一项使用关联医疗记录的人群数据库研究
Int J Chron Obstruct Pulmon Dis. 2017 Jan 17;12:313-322. doi: 10.2147/COPD.S121389. eCollection 2017.
5
Comorbidity as a contributor to frequent severe acute exacerbation in COPD patients.合并症是慢性阻塞性肺疾病(COPD)患者频繁发生严重急性加重的一个因素。
Int J Chron Obstruct Pulmon Dis. 2016 Aug 4;11:1857-65. doi: 10.2147/COPD.S103063. eCollection 2016.
6
Identification of five clusters of comorbidities in a longitudinal Japanese chronic obstructive pulmonary disease cohort.在一个日本慢性阻塞性肺疾病纵向队列中识别出五组共病情况。
Respir Med. 2016 Aug;117:272-9. doi: 10.1016/j.rmed.2016.07.002. Epub 2016 Jul 7.
7
Lung and kidney: a dangerous liaison? A population-based cohort study in COPD patients in Italy.肺与肾:危险关联?意大利慢性阻塞性肺疾病患者的一项基于人群的队列研究。
Int J Chron Obstruct Pulmon Dis. 2017 Jan 27;12:443-450. doi: 10.2147/COPD.S119390. eCollection 2017.
8
Diabetes mellitus in patients with chronic obstructive pulmonary disease-The impact on mortality.慢性阻塞性肺疾病患者的糖尿病——对死亡率的影响
PLoS One. 2017 Apr 14;12(4):e0175794. doi: 10.1371/journal.pone.0175794. eCollection 2017.
9
Chronic obstructive pulmonary disease and allied conditions is a strong independent risk factor for osteoporosis and pathologic fractures: a population-based cohort study.慢性阻塞性肺疾病及相关疾病是骨质疏松症和病理性骨折的一个强有力的独立危险因素:一项基于人群的队列研究。
QJM. 2015 Aug;108(8):633-40. doi: 10.1093/qjmed/hcv012. Epub 2015 Jan 21.
10
Evidence of potential bias in a comparison of β blockers and calcium channel blockers in patients with chronic obstructive pulmonary disease and acute coronary syndrome: results of a multinational study.β 受体阻滞剂和钙通道阻滞剂治疗慢性阻塞性肺疾病合并急性冠状动脉综合征患者的潜在偏倚证据:一项多国研究结果。
BMJ Open. 2017 Mar 31;7(3):e012997. doi: 10.1136/bmjopen-2016-012997.

本文引用的文献

1
Matching on the disease risk score in comparative effectiveness research of new treatments.在新疗法的比较效果研究中对疾病风险评分进行匹配。
Pharmacoepidemiol Drug Saf. 2015 Sep;24(9):951-61. doi: 10.1002/pds.3810. Epub 2015 Jun 25.
2
Ignoring the matching variables in cohort studies - when is it valid and why?在队列研究中忽略匹配变量——何时有效以及为什么?
Stat Med. 2013 Nov 30;32(27):4696-708. doi: 10.1002/sim.5879. Epub 2013 Jun 12.
3
Postoperative complications in patients with obstructive sleep apnea: a retrospective matched cohort study.
阻塞性睡眠呼吸暂停患者的术后并发症:一项回顾性匹配队列研究。
Can J Anaesth. 2009 Nov;56(11):819-28. doi: 10.1007/s12630-009-9190-y.
4
Risk of cataract among idiopathic thrombocytopenic purpura patients in the UK general practice research database.英国全科医学研究数据库中特发性血小板减少性紫癜患者患白内障的风险。
Pharmacoepidemiol Drug Saf. 2009 May;18(5):380-5. doi: 10.1002/pds.1723.
5
Use of disease risk scores in pharmacoepidemiologic studies.疾病风险评分在药物流行病学研究中的应用。
Stat Methods Med Res. 2009 Feb;18(1):67-80. doi: 10.1177/0962280208092347. Epub 2008 Jun 18.
6
From COPD to chronic systemic inflammatory syndrome?从慢性阻塞性肺疾病到慢性全身性炎症综合征?
Lancet. 2007 Sep 1;370(9589):797-9. doi: 10.1016/S0140-6736(07)61383-X.
7
Patterns of comorbidities in newly diagnosed COPD and asthma in primary care.基层医疗中新诊断慢性阻塞性肺疾病和哮喘的共病模式。
Chest. 2005 Oct;128(4):2099-107. doi: 10.1378/chest.128.4.2099.
8
Medical event profiling of COPD patients.慢性阻塞性肺疾病(COPD)患者的医疗事件概况分析
Pharmacoepidemiol Drug Saf. 2004 Aug;13(8):547-55. doi: 10.1002/pds.931.
9
Are patients with asthma at increased risk of coronary heart disease?哮喘患者患冠心病的风险会增加吗?
Int J Epidemiol. 2004 Aug;33(4):743-8. doi: 10.1093/ije/dyh081. Epub 2004 May 6.
10
The influence of co-morbidity on health-related quality of life in asthma and COPD patients.
Respir Med. 2003 May;97(5):468-75. doi: 10.1053/rmed.2002.1463.